» Articles » PMID: 30815397

Evaluation of ATM Kinase Inhibitor KU-55933 As Potential Anti- Agent

Overview
Date 2019 Mar 1
PMID 30815397
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

is an apicomplexan protozoan parasite with a complex life cycle composed of multiple stages that infect mammals and birds. Tachyzoites rapidly replicate within host cells to produce acute infection during which the parasite disseminates to tissues and organs. Highly replicative cells are subject to Double Strand Breaks (DSBs) by replication fork collapse and ATM, a member of the phosphatidylinositol 3-kinase (PI3K) family, is a key factor that initiates DNA repair and activates cell cycle checkpoints. Here we demonstrate that the treatment of intracellular tachyzoites with the PI3K inhibitor caffeine or ATM kinase-inhibitor KU-55933 affects parasite replication rate in a dose-dependent manner. KU-55933 affects intracellular tachyzoite growth and induces G1-phase arrest. Addition of KU-55933 to extracellular tachyzoites also leads to a significant reduction of tachyzoite replication upon infection of host cells. ATM kinase phosphorylates H2A.X (γH2AX) to promote DSB damage repair. The level of γH2AX increases in tachyzoites treated with camptothecin (CPT), a drug that generates fork collapse, but this increase was not observed when co-administered with KU-55933. These findings support that KU-55933 is affecting the ATM-like kinase (TgATM). The combination of KU-55933 and other DNA damaging agents such as methyl methane sulfonate (MMS) and CPT produce a synergic effect, suggesting that TgATM kinase inhibition sensitizes the parasite to damaged DNA. By contrast, hydroxyurea (HU) did not further inhibit tachyzoite replication when combined with KU-55933.

Citing Articles

Sickle Cell Disease and Gut Health: The Influence of Intestinal Parasites and the Microbiome on Angolan Children.

Delgadinho M, Ginete C, Santos B, de Vasconcelos J, Arez A, Brito M Int J Mol Sci. 2024; 25(13).

PMID: 39000364 PMC: 11242675. DOI: 10.3390/ijms25137258.


The Effects and Mechanism of ATM Kinase Inhibitors in .

Xue Y, Ying Z, Wang F, Yin M, Pei Y, Liu J Int J Mol Sci. 2024; 25(13).

PMID: 39000057 PMC: 11241798. DOI: 10.3390/ijms25136947.


Evaluation of topotecan and 10-hydroxycamptothecin on Toxoplasma gondii: Implications on baseline DNA damage and repair efficiency.

Cristaldi C, Saldarriaga Cartagena A, Ganuza A, Sullivan Jr W, Angel S, Vanagas L Int J Parasitol Drugs Drug Resist. 2023; 23:120-129.

PMID: 38043188 PMC: 10730954. DOI: 10.1016/j.ijpddr.2023.11.004.


Histone variant H2B.Z acetylation is necessary for maintenance of Toxoplasma gondii biological fitness.

Vanagas L, Munoz D, Cristaldi C, Ganuza A, Najera R, Bonardi M Biochim Biophys Acta Gene Regul Mech. 2023; 1866(3):194943.

PMID: 37217032 PMC: 10524646. DOI: 10.1016/j.bbagrm.2023.194943.


Histone variant H2B.Z acetylation is necessary for maintenance of biological fitness.

Vanagas L, Munoz D, Cristaldi C, Ganuza A, Najera R, Bonardi M bioRxiv. 2023; .

PMID: 36824796 PMC: 9949044. DOI: 10.1101/2023.02.14.528480.


References
1.
Sarkaria J . Identifying inhibitors of ATM and ATR kinase activities. Methods Mol Med. 2003; 85:49-56. DOI: 10.1385/1-59259-380-1:49. View

2.
Weber A, Ryan A . ATM and ATR as therapeutic targets in cancer. Pharmacol Ther. 2014; 149:124-38. DOI: 10.1016/j.pharmthera.2014.12.001. View

3.
Takahashi A, Mori E, Su X, Nakagawa Y, Okamoto N, Uemura H . ATM is the predominant kinase involved in the phosphorylation of histone H2AX after heating. J Radiat Res. 2010; 51(4):417-22. DOI: 10.1269/jrr.10015. View

4.
Zhou W, Quan J, Lee Y, Shin D, Cha G . Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway. PLoS One. 2013; 8(6):e66306. PMC: 3688893. DOI: 10.1371/journal.pone.0066306. View

5.
Cristini A, Park J, Capranico G, Legube G, Favre G, Sordet O . DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions. Nucleic Acids Res. 2015; 44(3):1161-78. PMC: 4756817. DOI: 10.1093/nar/gkv1196. View